Drug Type ASO |
Synonyms- |
Target |
Mechanism OTCase stimulants(Ornithine carbamoyltransferase stimulants) |
Therapeutic Areas |
Active Indication- |
Originator Organization Camp4 Therapeutics Corp.Startup |
Active Organization- |
Inactive Organization Camp4 Therapeutics Corp.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ornithine Carbamoyltransferase Deficiency Disease | Preclinical | US | Camp4 Therapeutics Corp.Startup | 26 Sep 2021 |
Urea Cycle Disorders, Inborn | Preclinical | US | Camp4 Therapeutics Corp.Startup | 26 Sep 2021 |